Aspen Aerogels Inc (ASPN) Q3 2026 Earnings Call Highlights: Revenue and Adjusted EBITDA

Aspen Aerogels (ASPN) reported Q3 2026 revenue of $85.2M and adjusted EBITDA of $19.8M, but incurred $15.1M in incident-related costs. Q4 revenue guidance is $60-75M. The company expects East Providence facility restoration to complete by H1 2027. CEO Donald Young discussed growth opportunities in data centers, LNG, and battery energy storage, but no plans for European fabrication.

Original reporting
Published Nov 5, 2026, 11:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 11:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Aspen Aerogels Inc (ASPN) Q3 2026 Earnings Call Highlights: Revenue and Adjusted EBITDA — source image
Decision brief

The 30-second read

$ASPNBearishMed
01

Why it matters

The earnings miss and guidance cut suggest near‑term downside, but management cites progress on subsea projects and data‑center orders that could improve future performance.

02

Market read

First‑time disclosure of Aspen Aerogels' Q3 loss, incident costs, and reduced Q4 guidance, creating actionable insight for traders.

03

What to watch

Potential upside from upcoming European warehouse expansion and battery‑storage revenue beginning in 2027 could mitigate short‑term pressure.

Relevance 7/10Novelty 7/10Timing: post‑earnings today

Background

Aspen Aerogels reported its Q3 2026 results, highlighting incident‑related expenses at its East Providence plant and providing lowered guidance for Q4 2026.

Company-level read

Ticker impact

$ASPNBearishHigh confidence
Context

Q3 2026 earnings disclosed a $10.4M GAAP loss, $19.8M adjusted EBITDA and $15.1M incident costs, plus lowered Q4 guidance of $60‑75M.

Expected impact

likely pressure as investors price in higher costs and weaker guidance

Evidence & confidence

The disclosed loss, sizable incident expenses and below‑trend revenue guidance create immediate downside risk.

Market effects

Thermal‑barrier and aerogel segment may see tighter margins industry‑wide due to incident‑related cost pressures.

North American investors may adjust exposure; European expansion plans remain limited.

Limited to niche industrial materials market; no broad macro effect.

Counterpoint

If the incident costs are one‑off and the company can secure insurance reimbursements, the stock may rebound on the upside of new data‑center and subsea contracts.

Key entities

  • Donald Young

    CEO who discussed incident costs and future opportunities.

  • Grant Thoele

    CFO who provided financial details and guidance.

Related articles

$ASPNMed

Aspen Aerogels Q3 Earnings Call Highlights

Aspen Aerogels reported Q3 revenue of $45.3M, up 54% sequentially, driven by GM and European automakers. Gross margin improved to 24% (41% ex-incident costs). The company forecasts Q4 revenue of $60M-$75M and full-year revenue of $233M-$248M. Aspen expects growth in battery energy storage and data center markets.

$ASPNMed

Aspen Aerogels Q2 Earnings Call Highlights

Aspen Aerogels (ASPN) reported Q2 gross profit of $3.3M (7% margin) after $5.3M of incremental costs tied to an April explosion at its East Providence plant. Adjusted gross profit was $8.6M (17%). GAAP net loss was $23.3M. The company is restarting the plant and expects full capacity in 1H 2027, while raising 2026 European Thermal Barrier revenue outlook to $20M-$30M.

$ASPNMed

Beerenberg Prevails in Patent Case Against Aspen Aerogels

South Korea’s Patent Court invalidated three Aspen Aerogels patents covering improved hydrophobic aerogel material, according to the company’s press release. The ruling upheld the Intellectual Property Trial and Appeal Board’s view that the patents failed patentability requirements. Beerenberg, an insulation-products firm, said the decision removes uncertainty over infringement claims.